This mechanistically explains how ALS-T2DM serum and ALS-T2DM-IgG promote K+-evoked [Ca2+]i responses and pinpoints that CaV1.2 channels most likely serve as downstream targets of ALS-T2DM serum and ALS-T2DM-IgG. Here, CACNA1C is linked to type 2 diabetes mellitus.